Growth Metrics

Jazz Pharmaceuticals (JAZZ) Current Taxes (2016 - 2025)

Jazz Pharmaceuticals has reported Current Taxes over the past 14 years, most recently at $56.4 million for Q4 2025.

  • Quarterly Current Taxes rose 200.62% to $56.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.4 million through Dec 2025, up 200.62% year-over-year, with the annual reading at $56.4 million for FY2025, 200.62% up from the prior year.
  • Current Taxes was $56.4 million for Q4 2025 at Jazz Pharmaceuticals, down from $91.1 million in the prior quarter.
  • Over five years, Current Taxes peaked at $91.1 million in Q3 2025 and troughed at $3.6 million in Q2 2021.
  • The 5-year median for Current Taxes is $37.6 million (2023), against an average of $40.6 million.
  • Biggest five-year swings in Current Taxes: tumbled 93.49% in 2021 and later skyrocketed 1065.1% in 2023.
  • Tracing JAZZ's Current Taxes over 5 years: stood at $9.6 million in 2021, then dropped by 19.68% to $7.7 million in 2022, then skyrocketed by 354.5% to $35.1 million in 2023, then tumbled by 46.52% to $18.8 million in 2024, then soared by 200.62% to $56.4 million in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $56.4 million, $91.1 million, and $78.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.